Profile data is unavailable for this security.
About the company
HitGen Inc is a China-based company mainly engaged in the early research and development of original innovative drugs. The Company focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The Company mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The Company conducts its businesses within the domestic market and to overseas markets.
- Revenue in CNY (TTM)409.13m
- Net income in CNY64.05m
- Incorporated2012
- Employees452.00
- LocationHitGen IncBlock 6,No.8 Huigu East 1st Road, Tianfu InternaCHENGDU 610200ChinaCHN
- Phone+86 2 885197385
- Fax+86 2 883310298
- Websitehttps://www.hitgen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Getein Biotech Inc | 1.31bn | 244.26m | 4.58bn | 2.14k | 18.75 | 1.73 | -- | 3.51 | 0.4816 | 0.4816 | 2.58 | 5.22 | 0.3502 | 1.61 | 2.77 | 611,337.70 | 6.63 | 13.25 | 9.24 | 18.45 | 66.13 | 65.57 | 18.92 | 28.13 | 1.97 | -- | 0.1857 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 889.82m | 233.59m | 4.73bn | 1.45k | 20.09 | 2.41 | -- | 5.31 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.43bn | 117.53m | 4.83bn | 584.00 | 39.98 | 2.66 | -- | 3.37 | 0.7061 | 0.7061 | 8.61 | 10.60 | 0.6264 | 1.66 | 4.42 | 2,451,945.00 | 6.11 | 5.31 | 7.69 | 6.76 | 82.35 | 86.02 | 9.76 | 8.10 | 3.25 | -- | 0.0809 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| HitGen Inc | 409.13m | 64.05m | 4.90bn | 452.00 | 76.31 | 3.55 | -- | 11.97 | 0.1601 | 0.1601 | 1.02 | 3.44 | 0.241 | 6.70 | 4.84 | 905,165.50 | 3.77 | 4.63 | 4.02 | 5.10 | 51.46 | 58.89 | 15.66 | 20.66 | 14.48 | 360.77 | 0.142 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| InventisBio Co Ltd | 194.13m | -249.28m | 4.92bn | 221.00 | -- | 2.54 | -- | 25.34 | -0.4289 | -0.4289 | 0.3348 | 3.35 | 0.0898 | -- | 1.96 | 878,429.50 | -11.53 | -- | -12.26 | -- | 97.85 | -- | -128.41 | -- | -- | -- | 0.0054 | -- | -- | -- | 41.26 | -- | -- | -- |
| Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 5.00bn | 295.00 | 113.60 | 4.00 | -- | 20.85 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
| Shanghai Haixin Group Co Ltd | 1.11bn | 171.70m | 5.05bn | 760.00 | 39.52 | 1.72 | -- | 4.55 | 0.1422 | 0.1422 | 0.9185 | 3.27 | 0.2246 | 7.19 | 9.32 | 1,458,849.00 | 4.05 | 2.68 | 4.57 | 3.06 | 46.37 | 44.55 | 18.02 | 11.17 | 2.83 | -- | 0.0089 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
Data as of May 28 2024. Currency figures normalised to HitGen Inc's reporting currency: Chinese Yuan Renminbi CNY
1.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 2.44m | 0.61% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 2.43m | 0.61% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 725.35k | 0.18% |
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 615.04k | 0.15% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 595.42k | 0.15% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 189.71k | 0.05% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 100.59k | 0.03% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 25.20k | 0.01% |
| BlackRock Advisors LLCas of 30 Apr 2024 | 13.05k | 0.00% |
| First-Trust Fund Management Co., Ltd.as of 31 Dec 2023 | 12.00k | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
